Biotech Sage Therapeutics skyrockets more than 60% after depression drug breakthrough

64% of patients achieved major depressive disorder remission using SAGE-217 in the 15th day of treatment, Sage says.
Source: CNBC

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>